Vildagliptin
Sold as Galvus, Jalra, Vysov, Galtin, Gulvatin, Vileptin, Vildagliptin accord, Hetviglap, Vilglav, Hetvidalipt, Vidamance, Viglymak, Makvild, Gavilda, Vilgozyd, Vidagliptin zydus, Vidiab, Vildagliptin unicorn, Vildagliptin shanur, Glucovus
(2S)-1-[2-[(3-Hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile
Drag to rotate. Structure from PubChem CID 6918537.
Background
Registration
- Applicants
- 14
- Registrations
- 20
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Novartis South Africa (Pty) Ltd | Galvus, Jalra | 50 mg | 410487, 451009 | S3 | None |
| Sandoz South Africa (Pty) LtdCancelled | Vysov | 50 mg | 451010 | S3 | None |
| Teva Pharmaceuticals (Pty) LtdCancelled | Galtin | Not stated | 520852 | S3 | None |
| Pharmacare limited û woodmead | Gulvatin | 50 mg | 530105 | S3 | None |
| Ranbaxy Pharmaceutical (Pty) Ltd | Vileptin | Not stated | 530333 | S3 | None |
| Accord Healthcare (Pty) Ltd | Vildagliptin accord | 50 mg | 550382 | S3 | PIPIL |
| Hetero Drugs South Africa (Pty) Ltd | Hetviglap, Vilglav, Hetvidalipt | 50 | 560488, 560489.488, 560490.488 | S3 | None |
| Pharma Dynamics (Pty) Ltd | Vidamance | 50 mg | 560772 | S3 | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Viglymak, Makvild | 50 | 570584, 570585.584 | S3 | None |
| Activo Health (Pty) Ltd | Gavilda | Not stated | 570635 | S3 | None |
| Zydus Healthcare (Pty) Ltd | Vilgozyd, Vidagliptin zydus | Not stated | 570851, 570852.851 | S3 | None |
| Pharma-q (Pty) Ltd | Vidiab | 50 mg | 590101 | S3 | None |
| Unicorn Pharmaceuticals (Pty) Ltd | Vildagliptin unicorn | 50 mg | 590605 | S3 | PIPIL |
| Austell Pharmaceuticals (Pty) Ltd | Vildagliptin shanur, Glucovus | 50 mg | 590966, 590967.966 | S3 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Galvus 50 MG EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | 50 mg | 41048741/21.2/0487 | Registered | S3 | None |
| Jalra 50 MG EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | 50 mg | 45100945/21.2/1009 | Registered | S3 | None |
| Vysov 50 MG EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | 50 mg | 45101045/21.2/1010 | Cancelled | S3 | None |
| Galtin EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | Not listed | 52085252/21.2/0852 | Cancelled | S3 | None |
| Gulvatin 50 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | 50 mg | 53010553/21.2/0105 | Registered | S3 | None |
| Vileptin EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | Not listed | 53033353/21.2/0333 | Registered | S3 | None |
| Vildagliptin 50 accord EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | 50 mgTablet | 55038255/21.2/0382Approved 23 September 2024 | Registered | S3 | PIPIL |
| Hetviglap 50 EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | 50 | 56048856/21.2/0488 | Registered | S3 | None |
| Vilglav 50 EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | 50 | 560489.48856/21.2/0489.488 | Registered | S3 | None |
| Hetvidalipt 50 EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | 50 | 560490.48856/21.2/0490.488 | Registered | S3 | None |
| Vidamance 50 MG EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg | 50 mg | 56077256/21.2/0772 | Registered | S3 | None |
| Viglymak 50 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | 50 | 57058457/21.2/0584 | Registered | S3 | None |
| Makvild 50 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | 50 | 570585.58457/21.2/0585.584 | Registered | S3 | None |
| Gavilda Each Tablet contains: Vildagliptin 50,0 mg | Not listed | 57063557/21.2/0635 | Registered | S3 | None |
| Vilgozyd EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | Not listed | 57085157/21.2/0851 | Registered | S3 | None |
| Vidagliptin zydus EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | Not listed | 570852.85157/21.2/0852.851 | Registered | S3 | None |
| Vidiab 50 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | 50 mg | 59010159/21.2/0101 | Registered | S3 | None |
| Vildagliptin 50 unicorn EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | 50 mgTablet | 59060559/21.2/0605Approved 21 July 2026 | Registered | S3 | PIPIL |
| Vildagliptin 50 MG shanur EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg | 50 mg | 59096659/21.2/0966 | Registered | S3 | None |
| Glucovus 50 MG EACH TABLET CONTAINS: VIDAGLIPTIN 50,0 mg | 50 mg | 590967.96659/21.2/0967.966 | Registered | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Vildagliptin
S3: Vildagliptin
Consolidated Schedules 06 July 2026, line 4386
Pharmacological class: Oral hypoglycaemics. (class 21.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Vildagliptin 50 accord, Accord Healthcare (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.